Innovation & Technology
University Hospitals Provides Life-Saving Innovation and Technology
Caring for those with brain tumors requires the use of highly specialized brain monitoring and neuroimaging equipment. This equipment guides the therapies used to rid the brain of diseased tissue without damaging healthy tissue.
The leading technology available at University Hospitals Neurological Institute’s Brain Tumor & Neuro-Oncology Center includes:
- NeuroBlate® technology (laser interstitial thermal therapy), which uses magnetic resonance imaging (MRI)-guided lasers to destroy tumors without damaging the surrounding healthy tissue. This minimally invasive approach is especially effective in treating glioblastoma, one of the most aggressive and difficult to treat types of brain cancer. UH Cleveland Medical Center was among the first in the world to use and help pioneer this technology and is still one of a limited number of hospitals in the United States that offer this service.
- CyberKnife®, a painless, noninvasive robotic radiation technology that gives patients new hope for treatment of tumors and lesions previously considered untreatable or inoperable.
- Gamma Knife radiosurgery, which delivers critical radiation to a precisely targeted area, sparing surrounding tissue. With this noninvasive procedure, the targeted tissue receives the highest dose of radiation.
- Intraoperative MRI operating suites, which allow our surgical team to use MRI imaging to track surgical progress in real-time. The Brain Tumor & Neuro-Oncology Center built one of the world’s first intraoperative MRI operating suites, which was the first of its kind in Ohio. The suite is integrated with other state-of-the-art techniques such as awake brain mapping of motor and language functions to enable the safest possible surgery.
- Proton therapy: University Hospitals is the first in Ohio to offer proton therapy, an advanced radiation therapy technique that can precisely target tumors while sparing healthy tissue. This painless outpatient procedure allows patients to continue their normal everyday activities throughout treatment. It has the potential to lessen side effects from treatment and can reduce the risk of developing radiation-induced secondary cancers years after treatment is completed.